Literature DB >> 32701288

Data Set Augmentation Allows Deep Learning-Based Virtual Screening to Better Generalize to Unseen Target Classes and Highlight Important Binding Interactions.

Jack Scantlebury1, Nathan Brown2, Frank Von Delft3,4,5, Charlotte M Deane1.   

Abstract

Current deep learning methods for structure-based virtual screening take the structures of both the protein and the ligand as input but make little or no use of the protein structure when predicting ligand binding. Here, we show how a relatively simple method of data set augmentation forces such deep learning methods to take into account information from the protein. Models trained in this way are more generalizable (make better predictions on protein/ligand complexes from a different distribution to the training data). They also assign more meaningful importance to the protein and ligand atoms involved in binding. Overall, our results show that data set augmentation can help deep learning-based virtual screening to learn physical interactions rather than data set biases.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32701288      PMCID: PMC7611237          DOI: 10.1021/acs.jcim.0c00263

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  17 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Large-scale similarity search profiling of ChEMBL compound data sets.

Authors:  Kathrin Heikamp; Jürgen Bajorath
Journal:  J Chem Inf Model       Date:  2011-07-14       Impact factor: 4.956

3.  Boosting Docking-Based Virtual Screening with Deep Learning.

Authors:  Janaina Cruz Pereira; Ernesto Raúl Caffarena; Cicero Nogueira Dos Santos
Journal:  J Chem Inf Model       Date:  2016-11-29       Impact factor: 4.956

4.  Protein Family-Specific Models Using Deep Neural Networks and Transfer Learning Improve Virtual Screening and Highlight the Need for More Data.

Authors:  Fergus Imrie; Anthony R Bradley; Mihaela van der Schaar; Charlotte M Deane
Journal:  J Chem Inf Model       Date:  2018-10-16       Impact factor: 4.956

Review 5.  Virtual screening strategies in drug discovery: a critical review.

Authors:  A Lavecchia; C Di Giovanni
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

Review 6.  Applications of machine learning in drug discovery and development.

Authors:  Jessica Vamathevan; Dominic Clark; Paul Czodrowski; Ian Dunham; Edgardo Ferran; George Lee; Bin Li; Anant Madabhushi; Parantu Shah; Michaela Spitzer; Shanrong Zhao
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

7.  Interaction prediction in structure-based virtual screening using deep learning.

Authors:  Adam Gonczarek; Jakub M Tomczak; Szymon Zaręba; Joanna Kaczmar; Piotr Dąbrowski; Michał J Walczak
Journal:  Comput Biol Med       Date:  2017-09-14       Impact factor: 4.589

8.  Most Ligand-Based Classification Benchmarks Reward Memorization Rather than Generalization.

Authors:  Izhar Wallach; Abraham Heifets
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

9.  Protein-Ligand Scoring with Convolutional Neural Networks.

Authors:  Matthew Ragoza; Joshua Hochuli; Elisa Idrobo; Jocelyn Sunseri; David Ryan Koes
Journal:  J Chem Inf Model       Date:  2017-04-11       Impact factor: 4.956

10.  Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.

Authors:  Michael M Mysinger; Michael Carchia; John J Irwin; Brian K Shoichet
Journal:  J Med Chem       Date:  2012-07-05       Impact factor: 7.446

View more
  9 in total

1.  Scoring Functions for Protein-Ligand Binding Affinity Prediction using Structure-Based Deep Learning: A Review.

Authors:  Rocco Meli; Garrett M Morris; Philip C Biggin
Journal:  Front Bioinform       Date:  2022-06-17

2.  Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.

Authors:  Paola Ruiz Puentes; Laura Rueda-Gensini; Natalia Valderrama; Isabela Hernández; Cristina González; Laura Daza; Carolina Muñoz-Camargo; Juan C Cruz; Pablo Arbeláez
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Learning protein-ligand binding affinity with atomic environment vectors.

Authors:  Rocco Meli; Andrew Anighoro; Mike J Bodkin; Garrett M Morris; Philip C Biggin
Journal:  J Cheminform       Date:  2021-08-14       Impact factor: 5.514

4.  DLAB-Deep learning methods for structure-based virtual screening of antibodies.

Authors:  Constantin Schneider; Andrew Buchanan; Bruck Taddese; Charlotte M Deane
Journal:  Bioinformatics       Date:  2021-09-21       Impact factor: 6.937

5.  Transferability of Geometric Patterns from Protein Self-Interactions to Protein-Ligand Interactions.

Authors:  Antoine Koehl; Milind Jagota; Dan D Erdmann-Pham; Alexander Fung; Yun S Song
Journal:  Pac Symp Biocomput       Date:  2022

6.  PIGNet: a physics-informed deep learning model toward generalized drug-target interaction predictions.

Authors:  Seokhyun Moon; Wonho Zhung; Soojung Yang; Jaechang Lim; Woo Youn Kim
Journal:  Chem Sci       Date:  2022-02-07       Impact factor: 9.825

7.  AtomNet PoseRanker: Enriching Ligand Pose Quality for Dynamic Proteins in Virtual High-Throughput Screens.

Authors:  Kate A Stafford; Brandon M Anderson; Jon Sorenson; Henry van den Bedem
Journal:  J Chem Inf Model       Date:  2022-03-02       Impact factor: 4.956

8.  Antiviral nanoparticle ligands identified with datamining and high-throughput virtual screening.

Authors:  Edward Peter Booker; Ghassan E Jabbour
Journal:  RSC Adv       Date:  2021-07-01       Impact factor: 4.036

9.  Galaxy workflows for fragment-based virtual screening: a case study on the SARS-CoV-2 main protease.

Authors:  Simon Bray; Tim Dudgeon; Rachael Skyner; Rolf Backofen; Björn Grüning; Frank von Delft
Journal:  J Cheminform       Date:  2022-04-12       Impact factor: 5.514

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.